Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

"When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.” Continue reading →

Devastating FDA Safety Review of Avandia

Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
Continue reading →

12-Year Old Denis Matez: Dead of Psych Drug Cocktail Rx by Psychiatrist

Twelve-year old, Denis Matez (weighing 68 lbs) is a human casualty of psychotropic drug "overmedication"– a notorious psychiatrist entrusted with the care of 800 Florida children in Florida foster care prescribed lethal mega doses for unapproved uses. Continue reading →

How to Stop Epidemic Antipsychotic Drug Prescribing

AHRP PROPOSAL:
Any FDA-approved drug, whose manufacturer has been found by a court of law or the Department of Justice–to have illegally marketed the drug by concealing risks or incidence of adverse effects, or making unsupported claims of clinical benefit–should be denied coverage by taxpayer funded insurance programs–including Medicaid, Medicare, VeteranstAffairs. Continue reading →

In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment

Unlike patients in other fields of medicine, those  who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
Continue reading →